Printer Friendly

World pharmaceutical chemicals demand to increase 6.3% annually through the year 2005. (News Release).

The world pharmaceutical chemicals market will increase 6.3 percent annually to US$83.5 billion in 2005. The eight largest drug-producing countries--the US, Japan, Germany, France, China, the United Kingdom, Italy and Switzerland -- will account for almost 80 percent of chemical demand. China will generate the fastest growth as economic expansion and outside investment fuel the upgrading of its national pharmaceutical industry. Demand growth in the other top drug-producing countries will range from 3.3 percent annually in Switzerland to nearly seven percent annually in the United States. Increasing generic competition, downward profit pressures and tighter price controls will prompt US, Japanese and West European drug makers to pursue greater production efficiencies. As a result, pharmaceutical chemical costs will fall under greater scrutiny and decrease as a percentage of total drug shipments. These and other trends are presented in World Pharmaceutical Chemicals, a new study from The Freedonia Group, Inc., a Cleveland-based industrial market research firm.

Bulk central nervous system agents demand will benefit from advances in a number of therapies. COX-2 inhibitors for arthritis, acetylcholinesterase inhibitors for Alzheimer's disease, lipase antagonists for obesity and second-generation serotonin reuptake inhibitors for depression will lead growth. Cardiovascular agents will benefit from an increased emphasis on prevention, especially new second-generation tissue plasminogen activators for preventing strokes and heart attacks. Humanized monoclonal antibodies for breast, ovarian and prostate cancer, along with thiazolidinedione antidiabetic agents, will spur rapid growth in demand for bulk hormones and related agents. Reduced dosage protease inhibitors for HIV and AIDS, along with advanced generation macrolides and quinolones, will boost sales of bulk anti-infective agents. Other new pharmaceutical chemicals projected for strong growth in demand include leukotriene blockers for asthma, monoclonal antibodies for transplant rejection, serotonin 5HT3 antagonists for irritable bowel syndrome and vaccines for influenza.

Patent restrictions will continue to deny merchant pharmaceutical chemical companies access to the most rapidly growing drug ingredients. However, many off-patent compounds will generate favorable sales gains based on worldwide trends promoting greater generic drug prescribing as well as on the expansion of preventive medicine and self-treatment activities among consumers. Analgesics, aminopenicillins, cephalosporins, first-generation antihistamines, acid reducers, herbal and related extracts, and calcium and iron minerals are among the pharmaceutical chemicals expected to fare well on the open market.

World Pharmaceutical Chemicals (published 01/2002, 438 pages) is available for $4,500 from The Freedonia Group, Inc., 767 Beta Drive, Cleveland, OH 44143-2326. For further details, please contact Corinne Gangloff by phone 440.684.9600, fax 440.646.0484 or e-mail pr@freedoniagroup.com. Information may also be obtained through www.freedoniagroup.com.
WORLD PHARMACEUTICAL CHEMICALS DEMAND
(billion US dollars)

 % Annual Growth
Item 1995 2000 2005 00/95 05/00

World Pharmaceutical
Chemicals Demand 44.3 61.5 83.5 6.8 6.3
 Central Nervous System 9.8 12.6 16.0 5.2 4.9
 Cardiovascular 6.2 8.5 11.4 6.5 6.0
 Hormones & Related 4.7 7.8 11.8 10.7 8.6
 Anti-Infective 5.1 7.3 10.7 7.4 7.9
 Respiratory 4.3 5.9 8.0 6.5 6.3
 Gastrointestinal 3.8 5.4 7.2 7.3 5.9
 Other 10.6 13.9 18.3 5.6 5.7

[c] 2002 by The Freedonia Group, Inc.
COPYRIGHT 2002 Subscription: $00.00 per year as of 1/94. Published irregularly. Contact Freedonia Group, 3570 Warrensville Cente
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:World pharmaceutical chemicals demand to increase 6.3% annually through the year 2005. (News Release).
Publication:Research Studies - Freedonia Group
Article Type:Brief Article
Geographic Code:00WOR
Date:Jan 28, 2002
Words:547
Previous Article:US fuel cells demand to expand nearly fourfold to $3.3 billion in the year 2006.
Next Article:World converted flexible packaging to grow 4.6% annually through the year 2005. (News Release).
Topics:


Related Articles
US demand for pharmaceutical chemicals is expected to increase 6.6 percent annually to $15.8 billion in 2002, with real annual growth averaging 3.2...
US PHARMACEUTICAL CHEMICAL DEMAND TO REACH $20.5 BILLION IN 2004.
US DEMAND FOR BIOTECHNOLOGY PHARMACEUTICALS TO INCREASE NEARLY 13 PERCENT ANNUALLY THROUGH 2004.
US CHIRAL CHEMICALS DEMAND TO INCREASE 9.4% ANNUALLY THROUGH THE YEAR 2005.
WORLD PHARMACEUTICAL PACKAGING DEMAND TO REACH US$18.2 BILLION IN THE YEAR 2005.
US gaskets & seals demand to reach $9.7 billion in the year 2005.
US pharmaceutical packaging demand to increase 4.3% annually through the year 2006.
World pharmaceutical packaging demand to exceed $30 billion in 2009.
Physical property instrumentation: China boosts growth.
US pouch demand to reach $6.5 billion in 2010.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters